A living systematic review protocol for COVID-19 clinical trial registrations [version 1; peer review: 2 approved]

Since the coronavirus disease 2019 (COVID-19) outbreak was identified in December 2019 in Wuhan, China, a strong response from the research community has been observed with the proliferation of independent clinical trials assessing diagnostic methods, therapeutic and prophylactic strategies. While t...

Full description

Bibliographic Details
Main Authors: Brittany J. Maguire, Philippe J. Guérin
Format: Article
Language:English
Published: Wellcome 2020-04-01
Series:Wellcome Open Research
Online Access:https://wellcomeopenresearch.org/articles/5-60/v1
_version_ 1818296172626837504
author Brittany J. Maguire
Philippe J. Guérin
author_facet Brittany J. Maguire
Philippe J. Guérin
author_sort Brittany J. Maguire
collection DOAJ
description Since the coronavirus disease 2019 (COVID-19) outbreak was identified in December 2019 in Wuhan, China, a strong response from the research community has been observed with the proliferation of independent clinical trials assessing diagnostic methods, therapeutic and prophylactic strategies. While there is no intervention for the prevention or treatment of COVID-19 with proven clinical efficacy to date, tools to distil the current research landscape by intervention, level of evidence and those studies likely powered to address future research questions is essential. This living systematic review aims to provide an open, accessible and frequently updated resource summarising the characteristics of COVID-19 clinical trial registrations. Weekly search updates of the WHO International Clinical Trials Registry Platform (ICTRP) and source registries will be conducted. Data extraction by two independent reviewers of trial characteristic variables including categorisation of trial design, geographic location, intervention type and targets, level of evidence and intervention adaptability to low resource settings will be completed. Descriptive and thematic synthesis will be conducted. A searchable and interactive visualisation of the results database will be created, and made openly available online. Weekly results from the continued search updates will be published and made available on the Infectious Diseases Data Observatory (IDDO) website (COVID-19 website). This living systematic review will provide a useful resource of COVID-19 clinical trial registrations for researchers in a rapidly evolving context. In the future, this sustained review will allow prioritisation of research targets for individual patient data meta-analysis.
first_indexed 2024-12-13T03:59:19Z
format Article
id doaj.art-e0a64622c3ca41ffb7a82035838491df
institution Directory Open Access Journal
issn 2398-502X
language English
last_indexed 2024-12-13T03:59:19Z
publishDate 2020-04-01
publisher Wellcome
record_format Article
series Wellcome Open Research
spelling doaj.art-e0a64622c3ca41ffb7a82035838491df2022-12-22T00:00:31ZengWellcomeWellcome Open Research2398-502X2020-04-01510.12688/wellcomeopenres.15821.117353A living systematic review protocol for COVID-19 clinical trial registrations [version 1; peer review: 2 approved]Brittany J. Maguire0Philippe J. Guérin1Infectious Diseases Data Observatory (IDDO), Oxford, UKInfectious Diseases Data Observatory (IDDO), Oxford, UKSince the coronavirus disease 2019 (COVID-19) outbreak was identified in December 2019 in Wuhan, China, a strong response from the research community has been observed with the proliferation of independent clinical trials assessing diagnostic methods, therapeutic and prophylactic strategies. While there is no intervention for the prevention or treatment of COVID-19 with proven clinical efficacy to date, tools to distil the current research landscape by intervention, level of evidence and those studies likely powered to address future research questions is essential. This living systematic review aims to provide an open, accessible and frequently updated resource summarising the characteristics of COVID-19 clinical trial registrations. Weekly search updates of the WHO International Clinical Trials Registry Platform (ICTRP) and source registries will be conducted. Data extraction by two independent reviewers of trial characteristic variables including categorisation of trial design, geographic location, intervention type and targets, level of evidence and intervention adaptability to low resource settings will be completed. Descriptive and thematic synthesis will be conducted. A searchable and interactive visualisation of the results database will be created, and made openly available online. Weekly results from the continued search updates will be published and made available on the Infectious Diseases Data Observatory (IDDO) website (COVID-19 website). This living systematic review will provide a useful resource of COVID-19 clinical trial registrations for researchers in a rapidly evolving context. In the future, this sustained review will allow prioritisation of research targets for individual patient data meta-analysis.https://wellcomeopenresearch.org/articles/5-60/v1
spellingShingle Brittany J. Maguire
Philippe J. Guérin
A living systematic review protocol for COVID-19 clinical trial registrations [version 1; peer review: 2 approved]
Wellcome Open Research
title A living systematic review protocol for COVID-19 clinical trial registrations [version 1; peer review: 2 approved]
title_full A living systematic review protocol for COVID-19 clinical trial registrations [version 1; peer review: 2 approved]
title_fullStr A living systematic review protocol for COVID-19 clinical trial registrations [version 1; peer review: 2 approved]
title_full_unstemmed A living systematic review protocol for COVID-19 clinical trial registrations [version 1; peer review: 2 approved]
title_short A living systematic review protocol for COVID-19 clinical trial registrations [version 1; peer review: 2 approved]
title_sort living systematic review protocol for covid 19 clinical trial registrations version 1 peer review 2 approved
url https://wellcomeopenresearch.org/articles/5-60/v1
work_keys_str_mv AT brittanyjmaguire alivingsystematicreviewprotocolforcovid19clinicaltrialregistrationsversion1peerreview2approved
AT philippejguerin alivingsystematicreviewprotocolforcovid19clinicaltrialregistrationsversion1peerreview2approved
AT brittanyjmaguire livingsystematicreviewprotocolforcovid19clinicaltrialregistrationsversion1peerreview2approved
AT philippejguerin livingsystematicreviewprotocolforcovid19clinicaltrialregistrationsversion1peerreview2approved